nodes	percent_of_prediction	percent_of_DWPC	metapath
Cephalexin—SLC22A5—Dactinomycin—kidney cancer	0.143	0.232	CbGbCtD
Cephalexin—CYP2D6—Temsirolimus—kidney cancer	0.0714	0.115	CbGbCtD
Cephalexin—CYP3A4—Everolimus—kidney cancer	0.0672	0.108	CbGbCtD
Cephalexin—ALB—Erlotinib—kidney cancer	0.0543	0.0877	CbGbCtD
Cephalexin—CYP3A4—Temsirolimus—kidney cancer	0.0454	0.0733	CbGbCtD
Cephalexin—CYP2D6—Pazopanib—kidney cancer	0.0375	0.0605	CbGbCtD
Cephalexin—CYP2D6—Erlotinib—kidney cancer	0.0268	0.0432	CbGbCtD
Cephalexin—CYP3A4—Pazopanib—kidney cancer	0.0238	0.0385	CbGbCtD
Cephalexin—CYP2D6—Sorafenib—kidney cancer	0.0218	0.0351	CbGbCtD
Cephalexin—CYP2D6—Vinblastine—kidney cancer	0.0215	0.0347	CbGbCtD
Cephalexin—CYP3A4—Erlotinib—kidney cancer	0.017	0.0275	CbGbCtD
Cephalexin—CYP3A4—Paclitaxel—kidney cancer	0.0156	0.0251	CbGbCtD
Cephalexin—CYP3A4—Sorafenib—kidney cancer	0.0138	0.0223	CbGbCtD
Cephalexin—CYP3A4—Vinblastine—kidney cancer	0.0137	0.0221	CbGbCtD
Cephalexin—CYP3A4—Vincristine—kidney cancer	0.0134	0.0217	CbGbCtD
Cephalexin—CYP2D6—Doxorubicin—kidney cancer	0.0132	0.0213	CbGbCtD
Cephalexin—CYP3A4—Sunitinib—kidney cancer	0.0112	0.0181	CbGbCtD
Cephalexin—SLC22A8—nephron—kidney cancer	0.00975	0.126	CbGeAlD
Cephalexin—CYP3A4—Doxorubicin—kidney cancer	0.00839	0.0136	CbGbCtD
Cephalexin—SLC22A8—urine—kidney cancer	0.00782	0.101	CbGeAlD
Cephalexin—SLC22A5—Temsirolimus—Everolimus—kidney cancer	0.00558	1	CbGdCrCtD
Cephalexin—CYP3A4—urine—kidney cancer	0.00388	0.0501	CbGeAlD
Cephalexin—CYP2D6—urine—kidney cancer	0.00381	0.0493	CbGeAlD
Cephalexin—SLC22A6—nephron tubule—kidney cancer	0.00352	0.0455	CbGeAlD
Cephalexin—SLC22A6—cortex of kidney—kidney cancer	0.00301	0.0389	CbGeAlD
Cephalexin—SLC15A1—nephron tubule—kidney cancer	0.00293	0.0379	CbGeAlD
Cephalexin—SLC47A1—nephron tubule—kidney cancer	0.00274	0.0355	CbGeAlD
Cephalexin—SLC15A1—renal system—kidney cancer	0.00266	0.0344	CbGeAlD
Cephalexin—SLC15A1—kidney—kidney cancer	0.00257	0.0333	CbGeAlD
Cephalexin—SLC47A1—renal system—kidney cancer	0.00249	0.0323	CbGeAlD
Cephalexin—SLC47A1—kidney—kidney cancer	0.00241	0.0312	CbGeAlD
Cephalexin—SLC47A1—cortex of kidney—kidney cancer	0.00235	0.0304	CbGeAlD
Cephalexin—SLC47A1—gonad—kidney cancer	0.00224	0.0289	CbGeAlD
Cephalexin—SLC22A8—nephron tubule—kidney cancer	0.0021	0.0272	CbGeAlD
Cephalexin—SLC22A8—renal system—kidney cancer	0.00191	0.0248	CbGeAlD
Cephalexin—SLC22A8—kidney—kidney cancer	0.00185	0.0239	CbGeAlD
Cephalexin—SLC15A2—nephron tubule—kidney cancer	0.00183	0.0237	CbGeAlD
Cephalexin—SLC22A8—cortex of kidney—kidney cancer	0.0018	0.0233	CbGeAlD
Cephalexin—SLC15A2—renal system—kidney cancer	0.00166	0.0215	CbGeAlD
Cephalexin—SLC15A2—kidney—kidney cancer	0.00161	0.0208	CbGeAlD
Cephalexin—SLC22A5—nephron tubule—kidney cancer	0.00159	0.0206	CbGeAlD
Cephalexin—SLC15A2—cortex of kidney—kidney cancer	0.00157	0.0203	CbGeAlD
Cephalexin—SLC22A5—renal system—kidney cancer	0.00145	0.0187	CbGeAlD
Cephalexin—SLC22A5—kidney—kidney cancer	0.0014	0.0181	CbGeAlD
Cephalexin—SLC22A5—cortex of kidney—kidney cancer	0.00136	0.0176	CbGeAlD
Cephalexin—SLC22A5—cardiac atrium—kidney cancer	0.0013	0.0168	CbGeAlD
Cephalexin—CYP3A4—renal system—kidney cancer	0.000948	0.0123	CbGeAlD
Cephalexin—CYP2D6—renal system—kidney cancer	0.000933	0.0121	CbGeAlD
Cephalexin—CYP3A4—kidney—kidney cancer	0.000917	0.0119	CbGeAlD
Cephalexin—CYP2D6—kidney—kidney cancer	0.000902	0.0117	CbGeAlD
Cephalexin—Aplastic anaemia—Doxorubicin—kidney cancer	0.00039	0.00131	CcSEcCtD
Cephalexin—Urinary tract disorder—Paclitaxel—kidney cancer	0.00039	0.00131	CcSEcCtD
Cephalexin—Connective tissue disorder—Paclitaxel—kidney cancer	0.000388	0.0013	CcSEcCtD
Cephalexin—Leukopenia—Vincristine—kidney cancer	0.000387	0.0013	CcSEcCtD
Cephalexin—Urethral disorder—Paclitaxel—kidney cancer	0.000387	0.0013	CcSEcCtD
Cephalexin—Thrombocytopenia—Dactinomycin—kidney cancer	0.000387	0.0013	CcSEcCtD
Cephalexin—Pancytopenia—Capecitabine—kidney cancer	0.000384	0.00129	CcSEcCtD
Cephalexin—Dyspepsia—Sorafenib—kidney cancer	0.000382	0.00128	CcSEcCtD
Cephalexin—Abdominal pain—Erlotinib—kidney cancer	0.000381	0.00128	CcSEcCtD
Cephalexin—Body temperature increased—Erlotinib—kidney cancer	0.000381	0.00128	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.00038	0.00128	CcSEcCtD
Cephalexin—Neutropenia—Capecitabine—kidney cancer	0.000378	0.00127	CcSEcCtD
Cephalexin—Nausea—Pazopanib—kidney cancer	0.000376	0.00126	CcSEcCtD
Cephalexin—Convulsion—Vincristine—kidney cancer	0.000375	0.00126	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000374	0.00126	CcSEcCtD
Cephalexin—Fatigue—Sorafenib—kidney cancer	0.000374	0.00125	CcSEcCtD
Cephalexin—Erythema multiforme—Paclitaxel—kidney cancer	0.000373	0.00125	CcSEcCtD
Cephalexin—Hypersensitivity—Vinblastine—kidney cancer	0.000369	0.00124	CcSEcCtD
Cephalexin—Hypersensitivity—Everolimus—kidney cancer	0.000368	0.00124	CcSEcCtD
Cephalexin—Dyspepsia—Sunitinib—kidney cancer	0.000367	0.00123	CcSEcCtD
Cephalexin—Leukopenia—Gemcitabine—kidney cancer	0.000367	0.00123	CcSEcCtD
Cephalexin—Infestation NOS—Capecitabine—kidney cancer	0.000361	0.00121	CcSEcCtD
Cephalexin—Infestation—Capecitabine—kidney cancer	0.000361	0.00121	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Sunitinib—kidney cancer	0.00036	0.00121	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.00036	0.00121	CcSEcCtD
Cephalexin—Asthenia—Vinblastine—kidney cancer	0.00036	0.00121	CcSEcCtD
Cephalexin—Fatigue—Sunitinib—kidney cancer	0.00036	0.00121	CcSEcCtD
Cephalexin—Asthenia—Everolimus—kidney cancer	0.000358	0.0012	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.000358	0.0012	CcSEcCtD
Cephalexin—Immune system disorder—Paclitaxel—kidney cancer	0.000356	0.0012	CcSEcCtD
Cephalexin—Gastrointestinal pain—Sorafenib—kidney cancer	0.000355	0.00119	CcSEcCtD
Cephalexin—Pruritus—Everolimus—kidney cancer	0.000353	0.00119	CcSEcCtD
Cephalexin—Anaphylactic shock—Vincristine—kidney cancer	0.000353	0.00118	CcSEcCtD
Cephalexin—Arthralgia—Gemcitabine—kidney cancer	0.000349	0.00117	CcSEcCtD
Cephalexin—Blood alkaline phosphatase increased—Doxorubicin—kidney cancer	0.000347	0.00116	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000347	0.00116	CcSEcCtD
Cephalexin—Nervous system disorder—Vincristine—kidney cancer	0.000346	0.00116	CcSEcCtD
Cephalexin—Asthenia—Erlotinib—kidney cancer	0.000346	0.00116	CcSEcCtD
Cephalexin—Mental disorder—Paclitaxel—kidney cancer	0.000346	0.00116	CcSEcCtD
Cephalexin—Thrombocytopenia—Vincristine—kidney cancer	0.000346	0.00116	CcSEcCtD
Cephalexin—Hepatic function abnormal—Doxorubicin—kidney cancer	0.000345	0.00116	CcSEcCtD
Cephalexin—Urticaria—Sorafenib—kidney cancer	0.000344	0.00116	CcSEcCtD
Cephalexin—Diarrhoea—Vinblastine—kidney cancer	0.000343	0.00115	CcSEcCtD
Cephalexin—Abdominal pain—Sorafenib—kidney cancer	0.000343	0.00115	CcSEcCtD
Cephalexin—Body temperature increased—Sorafenib—kidney cancer	0.000343	0.00115	CcSEcCtD
Cephalexin—Diarrhoea—Everolimus—kidney cancer	0.000342	0.00115	CcSEcCtD
Cephalexin—Gastrointestinal pain—Sunitinib—kidney cancer	0.000341	0.00115	CcSEcCtD
Cephalexin—Hepatobiliary disease—Capecitabine—kidney cancer	0.000341	0.00115	CcSEcCtD
Cephalexin—Pruritus—Erlotinib—kidney cancer	0.000341	0.00114	CcSEcCtD
Cephalexin—Fatigue—Dactinomycin—kidney cancer	0.000341	0.00114	CcSEcCtD
Cephalexin—Agranulocytosis—Capecitabine—kidney cancer	0.000337	0.00113	CcSEcCtD
Cephalexin—Anaphylactic shock—Gemcitabine—kidney cancer	0.000335	0.00112	CcSEcCtD
Cephalexin—Dizziness—Vinblastine—kidney cancer	0.000332	0.00111	CcSEcCtD
Cephalexin—Dizziness—Everolimus—kidney cancer	0.00033	0.00111	CcSEcCtD
Cephalexin—Abdominal pain—Sunitinib—kidney cancer	0.00033	0.00111	CcSEcCtD
Cephalexin—Body temperature increased—Sunitinib—kidney cancer	0.00033	0.00111	CcSEcCtD
Cephalexin—Diarrhoea—Erlotinib—kidney cancer	0.00033	0.00111	CcSEcCtD
Cephalexin—Nervous system disorder—Gemcitabine—kidney cancer	0.000328	0.0011	CcSEcCtD
Cephalexin—Thrombocytopenia—Gemcitabine—kidney cancer	0.000328	0.0011	CcSEcCtD
Cephalexin—Feeling abnormal—Dactinomycin—kidney cancer	0.000326	0.00109	CcSEcCtD
Cephalexin—Haemoglobin—Capecitabine—kidney cancer	0.000325	0.00109	CcSEcCtD
Cephalexin—Skin disorder—Gemcitabine—kidney cancer	0.000325	0.00109	CcSEcCtD
Cephalexin—Haemorrhage—Capecitabine—kidney cancer	0.000324	0.00109	CcSEcCtD
Cephalexin—Hepatitis—Capecitabine—kidney cancer	0.000324	0.00109	CcSEcCtD
Cephalexin—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000323	0.00108	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000322	0.00108	CcSEcCtD
Cephalexin—Urinary tract disorder—Capecitabine—kidney cancer	0.00032	0.00107	CcSEcCtD
Cephalexin—Hypersensitivity—Sorafenib—kidney cancer	0.000319	0.00107	CcSEcCtD
Cephalexin—Vomiting—Vinblastine—kidney cancer	0.000319	0.00107	CcSEcCtD
Cephalexin—Dizziness—Erlotinib—kidney cancer	0.000319	0.00107	CcSEcCtD
Cephalexin—Connective tissue disorder—Capecitabine—kidney cancer	0.000318	0.00107	CcSEcCtD
Cephalexin—Vomiting—Everolimus—kidney cancer	0.000318	0.00107	CcSEcCtD
Cephalexin—Urethral disorder—Capecitabine—kidney cancer	0.000317	0.00107	CcSEcCtD
Cephalexin—Agitation—Paclitaxel—kidney cancer	0.000316	0.00106	CcSEcCtD
Cephalexin—Rash—Everolimus—kidney cancer	0.000315	0.00106	CcSEcCtD
Cephalexin—Dermatitis—Everolimus—kidney cancer	0.000315	0.00106	CcSEcCtD
Cephalexin—Headache—Vinblastine—kidney cancer	0.000314	0.00105	CcSEcCtD
Cephalexin—Angioedema—Paclitaxel—kidney cancer	0.000314	0.00105	CcSEcCtD
Cephalexin—Headache—Everolimus—kidney cancer	0.000313	0.00105	CcSEcCtD
Cephalexin—Body temperature increased—Dactinomycin—kidney cancer	0.000312	0.00105	CcSEcCtD
Cephalexin—Abdominal pain—Dactinomycin—kidney cancer	0.000312	0.00105	CcSEcCtD
Cephalexin—Asthenia—Sorafenib—kidney cancer	0.000311	0.00104	CcSEcCtD
Cephalexin—Leukopenia—Paclitaxel—kidney cancer	0.000307	0.00103	CcSEcCtD
Cephalexin—Hypersensitivity—Sunitinib—kidney cancer	0.000307	0.00103	CcSEcCtD
Cephalexin—Pruritus—Sorafenib—kidney cancer	0.000307	0.00103	CcSEcCtD
Cephalexin—Vomiting—Erlotinib—kidney cancer	0.000306	0.00103	CcSEcCtD
Cephalexin—Erythema multiforme—Capecitabine—kidney cancer	0.000306	0.00103	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000305	0.00102	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Vincristine—kidney cancer	0.000305	0.00102	CcSEcCtD
Cephalexin—Fatigue—Vincristine—kidney cancer	0.000304	0.00102	CcSEcCtD
Cephalexin—Rash—Erlotinib—kidney cancer	0.000304	0.00102	CcSEcCtD
Cephalexin—Dermatitis—Erlotinib—kidney cancer	0.000304	0.00102	CcSEcCtD
Cephalexin—Headache—Erlotinib—kidney cancer	0.000302	0.00101	CcSEcCtD
Cephalexin—Osteoarthritis—Doxorubicin—kidney cancer	0.000302	0.00101	CcSEcCtD
Cephalexin—Asthenia—Sunitinib—kidney cancer	0.000299	0.001	CcSEcCtD
Cephalexin—Nausea—Vinblastine—kidney cancer	0.000298	0.001	CcSEcCtD
Cephalexin—Convulsion—Paclitaxel—kidney cancer	0.000298	0.000999	CcSEcCtD
Cephalexin—Nausea—Everolimus—kidney cancer	0.000297	0.000996	CcSEcCtD
Cephalexin—Diarrhoea—Sorafenib—kidney cancer	0.000297	0.000996	CcSEcCtD
Cephalexin—Pruritus—Sunitinib—kidney cancer	0.000295	0.000991	CcSEcCtD
Cephalexin—Immune system disorder—Capecitabine—kidney cancer	0.000292	0.000982	CcSEcCtD
Cephalexin—Arthralgia—Paclitaxel—kidney cancer	0.000292	0.000982	CcSEcCtD
Cephalexin—Hypersensitivity—Dactinomycin—kidney cancer	0.000291	0.000977	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.00029	0.000975	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000289	0.00097	CcSEcCtD
Cephalexin—Fatigue—Gemcitabine—kidney cancer	0.000289	0.000969	CcSEcCtD
Cephalexin—Gastrointestinal pain—Vincristine—kidney cancer	0.000289	0.000969	CcSEcCtD
Cephalexin—Dizziness—Sorafenib—kidney cancer	0.000287	0.000963	CcSEcCtD
Cephalexin—Nausea—Erlotinib—kidney cancer	0.000286	0.000961	CcSEcCtD
Cephalexin—Diarrhoea—Sunitinib—kidney cancer	0.000285	0.000958	CcSEcCtD
Cephalexin—Mental disorder—Capecitabine—kidney cancer	0.000284	0.000952	CcSEcCtD
Cephalexin—Asthenia—Dactinomycin—kidney cancer	0.000283	0.000951	CcSEcCtD
Cephalexin—Confusional state—Paclitaxel—kidney cancer	0.000283	0.000949	CcSEcCtD
Cephalexin—Blood creatinine increased—Doxorubicin—kidney cancer	0.000283	0.000949	CcSEcCtD
Cephalexin—Anaphylactic shock—Paclitaxel—kidney cancer	0.00028	0.000941	CcSEcCtD
Cephalexin—Body temperature increased—Vincristine—kidney cancer	0.000279	0.000937	CcSEcCtD
Cephalexin—Abdominal pain—Vincristine—kidney cancer	0.000279	0.000937	CcSEcCtD
Cephalexin—Dizziness—Sunitinib—kidney cancer	0.000276	0.000926	CcSEcCtD
Cephalexin—Feeling abnormal—Gemcitabine—kidney cancer	0.000276	0.000926	CcSEcCtD
Cephalexin—Vomiting—Sorafenib—kidney cancer	0.000276	0.000925	CcSEcCtD
Cephalexin—Nervous system disorder—Paclitaxel—kidney cancer	0.000275	0.000923	CcSEcCtD
Cephalexin—Thrombocytopenia—Paclitaxel—kidney cancer	0.000274	0.000921	CcSEcCtD
Cephalexin—Rash—Sorafenib—kidney cancer	0.000273	0.000918	CcSEcCtD
Cephalexin—Dermatitis—Sorafenib—kidney cancer	0.000273	0.000917	CcSEcCtD
Cephalexin—Breast disorder—Doxorubicin—kidney cancer	0.000273	0.000915	CcSEcCtD
Cephalexin—Skin disorder—Paclitaxel—kidney cancer	0.000272	0.000914	CcSEcCtD
Cephalexin—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000272	0.000912	CcSEcCtD
Cephalexin—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.000272	0.000912	CcSEcCtD
Cephalexin—Headache—Sorafenib—kidney cancer	0.000272	0.000912	CcSEcCtD
Cephalexin—Diarrhoea—Dactinomycin—kidney cancer	0.00027	0.000907	CcSEcCtD
Cephalexin—Gastritis—Doxorubicin—kidney cancer	0.000267	0.000896	CcSEcCtD
Cephalexin—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000266	0.000893	CcSEcCtD
Cephalexin—Vomiting—Sunitinib—kidney cancer	0.000265	0.000891	CcSEcCtD
Cephalexin—Body temperature increased—Gemcitabine—kidney cancer	0.000265	0.000888	CcSEcCtD
Cephalexin—Rash—Sunitinib—kidney cancer	0.000263	0.000883	CcSEcCtD
Cephalexin—Dermatitis—Sunitinib—kidney cancer	0.000263	0.000882	CcSEcCtD
Cephalexin—Headache—Sunitinib—kidney cancer	0.000261	0.000877	CcSEcCtD
Cephalexin—Hypersensitivity—Vincristine—kidney cancer	0.00026	0.000873	CcSEcCtD
Cephalexin—Eosinophilia—Doxorubicin—kidney cancer	0.000258	0.000867	CcSEcCtD
Cephalexin—Nausea—Sorafenib—kidney cancer	0.000258	0.000865	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000255	0.000857	CcSEcCtD
Cephalexin—Asthenia—Vincristine—kidney cancer	0.000253	0.00085	CcSEcCtD
Cephalexin—Leukopenia—Capecitabine—kidney cancer	0.000252	0.000847	CcSEcCtD
Cephalexin—Vomiting—Dactinomycin—kidney cancer	0.000251	0.000843	CcSEcCtD
Cephalexin—Rash—Dactinomycin—kidney cancer	0.000249	0.000836	CcSEcCtD
Cephalexin—Nausea—Sunitinib—kidney cancer	0.000248	0.000832	CcSEcCtD
Cephalexin—Pancytopenia—Doxorubicin—kidney cancer	0.000248	0.000831	CcSEcCtD
Cephalexin—Dyspepsia—Paclitaxel—kidney cancer	0.000247	0.000828	CcSEcCtD
Cephalexin—Neutropenia—Doxorubicin—kidney cancer	0.000244	0.000818	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000242	0.000812	CcSEcCtD
Cephalexin—Fatigue—Paclitaxel—kidney cancer	0.000242	0.000811	CcSEcCtD
Cephalexin—Diarrhoea—Vincristine—kidney cancer	0.000241	0.000811	CcSEcCtD
Cephalexin—Asthenia—Gemcitabine—kidney cancer	0.00024	0.000806	CcSEcCtD
Cephalexin—Arthralgia—Capecitabine—kidney cancer	0.00024	0.000805	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000238	0.0008	CcSEcCtD
Cephalexin—Pruritus—Gemcitabine—kidney cancer	0.000237	0.000795	CcSEcCtD
Cephalexin—Nausea—Dactinomycin—kidney cancer	0.000235	0.000788	CcSEcCtD
Cephalexin—Dizziness—Vincristine—kidney cancer	0.000233	0.000783	CcSEcCtD
Cephalexin—Infestation NOS—Doxorubicin—kidney cancer	0.000232	0.00078	CcSEcCtD
Cephalexin—Infestation—Doxorubicin—kidney cancer	0.000232	0.00078	CcSEcCtD
Cephalexin—Confusional state—Capecitabine—kidney cancer	0.000232	0.000779	CcSEcCtD
Cephalexin—Feeling abnormal—Paclitaxel—kidney cancer	0.000231	0.000775	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.00023	0.000774	CcSEcCtD
Cephalexin—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000229	0.000769	CcSEcCtD
Cephalexin—Diarrhoea—Gemcitabine—kidney cancer	0.000229	0.000769	CcSEcCtD
Cephalexin—Nervous system disorder—Capecitabine—kidney cancer	0.000226	0.000757	CcSEcCtD
Cephalexin—Thrombocytopenia—Capecitabine—kidney cancer	0.000225	0.000756	CcSEcCtD
Cephalexin—Vomiting—Vincristine—kidney cancer	0.000224	0.000753	CcSEcCtD
Cephalexin—Skin disorder—Capecitabine—kidney cancer	0.000223	0.00075	CcSEcCtD
Cephalexin—Urticaria—Paclitaxel—kidney cancer	0.000223	0.000748	CcSEcCtD
Cephalexin—Rash—Vincristine—kidney cancer	0.000223	0.000747	CcSEcCtD
Cephalexin—Dermatitis—Vincristine—kidney cancer	0.000222	0.000746	CcSEcCtD
Cephalexin—Abdominal pain—Paclitaxel—kidney cancer	0.000222	0.000744	CcSEcCtD
Cephalexin—Body temperature increased—Paclitaxel—kidney cancer	0.000222	0.000744	CcSEcCtD
Cephalexin—Headache—Vincristine—kidney cancer	0.000221	0.000742	CcSEcCtD
Cephalexin—Hepatobiliary disease—Doxorubicin—kidney cancer	0.00022	0.000738	CcSEcCtD
Cephalexin—Agranulocytosis—Doxorubicin—kidney cancer	0.000217	0.000728	CcSEcCtD
Cephalexin—Vomiting—Gemcitabine—kidney cancer	0.000213	0.000715	CcSEcCtD
Cephalexin—Rash—Gemcitabine—kidney cancer	0.000211	0.000709	CcSEcCtD
Cephalexin—Dermatitis—Gemcitabine—kidney cancer	0.000211	0.000708	CcSEcCtD
Cephalexin—Haemoglobin—Doxorubicin—kidney cancer	0.00021	0.000704	CcSEcCtD
Cephalexin—Headache—Gemcitabine—kidney cancer	0.00021	0.000704	CcSEcCtD
Cephalexin—Nausea—Vincristine—kidney cancer	0.00021	0.000704	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.00021	0.000704	CcSEcCtD
Cephalexin—Haemorrhage—Doxorubicin—kidney cancer	0.000209	0.000701	CcSEcCtD
Cephalexin—Hepatitis—Doxorubicin—kidney cancer	0.000209	0.000701	CcSEcCtD
Cephalexin—Hypersensitivity—Paclitaxel—kidney cancer	0.000207	0.000693	CcSEcCtD
Cephalexin—Urinary tract disorder—Doxorubicin—kidney cancer	0.000206	0.000692	CcSEcCtD
Cephalexin—Connective tissue disorder—Doxorubicin—kidney cancer	0.000205	0.000688	CcSEcCtD
Cephalexin—Urethral disorder—Doxorubicin—kidney cancer	0.000205	0.000687	CcSEcCtD
Cephalexin—Dyspepsia—Capecitabine—kidney cancer	0.000202	0.00068	CcSEcCtD
Cephalexin—Asthenia—Paclitaxel—kidney cancer	0.000201	0.000675	CcSEcCtD
Cephalexin—Nausea—Gemcitabine—kidney cancer	0.000199	0.000668	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000199	0.000667	CcSEcCtD
Cephalexin—Fatigue—Capecitabine—kidney cancer	0.000198	0.000666	CcSEcCtD
Cephalexin—Pruritus—Paclitaxel—kidney cancer	0.000198	0.000666	CcSEcCtD
Cephalexin—Erythema multiforme—Doxorubicin—kidney cancer	0.000197	0.000662	CcSEcCtD
Cephalexin—Diarrhoea—Paclitaxel—kidney cancer	0.000192	0.000644	CcSEcCtD
Cephalexin—Feeling abnormal—Capecitabine—kidney cancer	0.00019	0.000636	CcSEcCtD
Cephalexin—Immune system disorder—Doxorubicin—kidney cancer	0.000189	0.000633	CcSEcCtD
Cephalexin—Gastrointestinal pain—Capecitabine—kidney cancer	0.000188	0.000631	CcSEcCtD
Cephalexin—Dizziness—Paclitaxel—kidney cancer	0.000185	0.000622	CcSEcCtD
Cephalexin—Mental disorder—Doxorubicin—kidney cancer	0.000183	0.000614	CcSEcCtD
Cephalexin—Urticaria—Capecitabine—kidney cancer	0.000183	0.000613	CcSEcCtD
Cephalexin—Abdominal pain—Capecitabine—kidney cancer	0.000182	0.00061	CcSEcCtD
Cephalexin—Body temperature increased—Capecitabine—kidney cancer	0.000182	0.00061	CcSEcCtD
Cephalexin—Vomiting—Paclitaxel—kidney cancer	0.000178	0.000598	CcSEcCtD
Cephalexin—Rash—Paclitaxel—kidney cancer	0.000177	0.000593	CcSEcCtD
Cephalexin—Dermatitis—Paclitaxel—kidney cancer	0.000177	0.000593	CcSEcCtD
Cephalexin—Headache—Paclitaxel—kidney cancer	0.000176	0.000589	CcSEcCtD
Cephalexin—Hypersensitivity—Capecitabine—kidney cancer	0.000169	0.000569	CcSEcCtD
Cephalexin—Agitation—Doxorubicin—kidney cancer	0.000167	0.00056	CcSEcCtD
Cephalexin—Nausea—Paclitaxel—kidney cancer	0.000167	0.000559	CcSEcCtD
Cephalexin—Asthenia—Capecitabine—kidney cancer	0.000165	0.000554	CcSEcCtD
Cephalexin—Pruritus—Capecitabine—kidney cancer	0.000163	0.000546	CcSEcCtD
Cephalexin—Leukopenia—Doxorubicin—kidney cancer	0.000163	0.000546	CcSEcCtD
Cephalexin—Convulsion—Doxorubicin—kidney cancer	0.000157	0.000528	CcSEcCtD
Cephalexin—Diarrhoea—Capecitabine—kidney cancer	0.000157	0.000528	CcSEcCtD
Cephalexin—Arthralgia—Doxorubicin—kidney cancer	0.000155	0.000519	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000154	0.000516	CcSEcCtD
Cephalexin—Dizziness—Capecitabine—kidney cancer	0.000152	0.000511	CcSEcCtD
Cephalexin—Confusional state—Doxorubicin—kidney cancer	0.00015	0.000502	CcSEcCtD
Cephalexin—Anaphylactic shock—Doxorubicin—kidney cancer	0.000148	0.000498	CcSEcCtD
Cephalexin—Vomiting—Capecitabine—kidney cancer	0.000146	0.000491	CcSEcCtD
Cephalexin—Nervous system disorder—Doxorubicin—kidney cancer	0.000145	0.000488	CcSEcCtD
Cephalexin—Thrombocytopenia—Doxorubicin—kidney cancer	0.000145	0.000487	CcSEcCtD
Cephalexin—Rash—Capecitabine—kidney cancer	0.000145	0.000487	CcSEcCtD
Cephalexin—Dermatitis—Capecitabine—kidney cancer	0.000145	0.000486	CcSEcCtD
Cephalexin—Headache—Capecitabine—kidney cancer	0.000144	0.000484	CcSEcCtD
Cephalexin—Skin disorder—Doxorubicin—kidney cancer	0.000144	0.000483	CcSEcCtD
Cephalexin—Nausea—Capecitabine—kidney cancer	0.000137	0.000459	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000135	0.000453	CcSEcCtD
Cephalexin—Dyspepsia—Doxorubicin—kidney cancer	0.000131	0.000438	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000128	0.00043	CcSEcCtD
Cephalexin—Fatigue—Doxorubicin—kidney cancer	0.000128	0.000429	CcSEcCtD
Cephalexin—Feeling abnormal—Doxorubicin—kidney cancer	0.000122	0.00041	CcSEcCtD
Cephalexin—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000121	0.000407	CcSEcCtD
Cephalexin—Urticaria—Doxorubicin—kidney cancer	0.000118	0.000395	CcSEcCtD
Cephalexin—Body temperature increased—Doxorubicin—kidney cancer	0.000117	0.000393	CcSEcCtD
Cephalexin—Abdominal pain—Doxorubicin—kidney cancer	0.000117	0.000393	CcSEcCtD
Cephalexin—Hypersensitivity—Doxorubicin—kidney cancer	0.000109	0.000367	CcSEcCtD
Cephalexin—Asthenia—Doxorubicin—kidney cancer	0.000106	0.000357	CcSEcCtD
Cephalexin—Pruritus—Doxorubicin—kidney cancer	0.000105	0.000352	CcSEcCtD
Cephalexin—Diarrhoea—Doxorubicin—kidney cancer	0.000101	0.000341	CcSEcCtD
Cephalexin—Dizziness—Doxorubicin—kidney cancer	9.81e-05	0.000329	CcSEcCtD
Cephalexin—Vomiting—Doxorubicin—kidney cancer	9.43e-05	0.000316	CcSEcCtD
Cephalexin—Rash—Doxorubicin—kidney cancer	9.35e-05	0.000314	CcSEcCtD
Cephalexin—Dermatitis—Doxorubicin—kidney cancer	9.34e-05	0.000314	CcSEcCtD
Cephalexin—Headache—Doxorubicin—kidney cancer	9.29e-05	0.000312	CcSEcCtD
Cephalexin—Nausea—Doxorubicin—kidney cancer	8.81e-05	0.000296	CcSEcCtD
